<SEC-DOCUMENT>0000921895-20-000531-index.html : 20200214
<SEC-HEADER>0000921895-20-000531.hdr.sgml : 20200214
<ACCEPTANCE-DATETIME>20200214145612
ACCESSION NUMBER:		0000921895-20-000531
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20200214
DATE AS OF CHANGE:		20200214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Forward Pharma A/S
		CENTRAL INDEX KEY:			0001604924
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			G7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88394
		FILM NUMBER:		20618381

	BUSINESS ADDRESS:	
		STREET 1:		OSTERGADE 24A, 1
		CITY:			COPENHAGEN
		STATE:			G7
		ZIP:			1100
		BUSINESS PHONE:		0114533444242

	MAIL ADDRESS:	
		STREET 1:		OSTERGADE 24A, 1
		CITY:			COPENHAGEN
		STATE:			G7
		ZIP:			1100

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOTECHNOLOGY VALUE FUND L P
		CENTRAL INDEX KEY:			0000918923
		STANDARD INDUSTRIAL CLASSIFICATION:	INVESTMENT ADVICE [6282]
		IRS NUMBER:				363924731
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		44 MONTGOMERY STREET
		STREET 2:		40TH FL
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		3125066500

	MAIL ADDRESS:	
		STREET 1:		44 MONTGOMERY STREET
		STREET 2:		40TH FL
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>sc13ga307422fwp_02142020.htm
<DESCRIPTION>AMENDMENT NO. 3 TO THE SCHEDULE 13G
<TEXT>
Document 1 - file: sc13ga307422fwp_02142020.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991to13ga307422fwp_021420.htm
<DESCRIPTION>JOINT FILING AGREEMENT
<TEXT>
Document 2 - file: ex991to13ga307422fwp_021420.htm

</DOCUMENT>
</SEC-DOCUMENT>